Lung cancer study aims to see how well osimertinib works in everyday practice
NCT ID NCT07028489
First seen Jun 24, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study is collecting information from 130 people with advanced EGFR-mutant non-small cell lung cancer who are starting treatment with osimertinib. Researchers want to see how long the drug controls the cancer in real-world settings, outside of strict clinical trial conditions. Participants will have their health data recorded at regular visits, and some will have scheduled imaging scans. The goal is to better understand how well osimertinib works in everyday practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- osimertinib
- What this could lead to
- If successful, this study could provide better real-world evidence on how well osimertinib works for EGFR-mutant lung cancer, helping doctors make more informed treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It does not test a new drug or intervention, so it cannot directly lead to a cure or new therapy. Results may also be limited by the specific patient group and data collection methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayhealth Cancer Center- Kent
RECRUITINGDover, Delaware, 19901, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Bayhealth Cancer Center- Sussex
RECRUITINGMilford, Delaware, 19963, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
John Muir Health
RECRUITINGWalnut Creek, California, 94598, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kootenai Clinic Cancer Services Coeur d'Alene
RECRUITINGCoeur d'Alene, Idaho, 83814, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Lankenau Medical Center
NOT_YET_RECRUITINGPaoli, Pennsylvania, 19301, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Northwest Oncology & Hematology
RECRUITINGElk Grove Village, Illinois, 60007, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oncology Consultants, P.A.
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Pacific Cancer Care
RECRUITINGMonterey, California, 93940, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Torrance Memorial Physician Network-Cancer Care
RECRUITINGTorrance, California, 90505, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can a radioactive tracer reveal whether immunotherapy is working?
- Can a new nucleotide analogue boost cancer treatment?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Can a Two-Pronged attack shrink Hard-to-Treat cancers?
- Can standard cancer treatment wake up the immune system? a study investigates.